The company said it would apply in coming months for U.S. regulatory approval.
Source link
Tags: AstraZeneca, AZN.LN, Biotechnology Services, C&E Industry News Filter, Content Types, corporate, Corporate/Industrial News, Demographic Health, development, Factiva Filters, FR:SAN, general news, Geriatric Health, government policy, GSK, GSK.LN, Health, healthcare, Healthcare/Life Sciences, Immunizations, industrial news, JNJ, Johnson & Johnson, life sciences, Medical Conditions, medical treatments, Medical Treatments/Procedures, medications, Moderna, MRNA, new product, New Product/Service Testing, new products, New Products/Services, PFE, Pfizer, Pharmaceuticals, political, Political/General News, procedures, product, Product/Service Approvals, products, Products/Services, regulation, Regulation/Government Policy, research, Research/Development, Respiratory Tract Diseases, SAN.FR, Sanofi, service approvals, service testing, services, specialized drugs, Specialized Drugs/Medications, SYND, UK:AZN, UK:GSK, Vaccines, WSJ-PRO-WSJ.com, wsjhealth
